Preskoči na sadržaj
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Jezik
Sva polja
Naslov
Autor
Tema
Signatura
ISBN/ISSN
Oznaka
Pronađi
Napredno
The interferon beta-1b 16-year...
Citiraj ovo
Pošalji tekstualnu poruku
Pošalji ovo e-mailom
Ispiši
Izvezi zapis
Izvezi u RefWorks
Izvezi u EndNoteWeb
Izvezi u EndNote
Stalna poveznica
The interferon beta-1b 16-year long-term follow-up study: Neutralizing antibodies and clinical outcomes
Bibliografski detalji
Glavni autori:
Reder, A
,
Ebers, G
,
Goodin, D
,
Li, D
,
Traboulsee, A
,
Beckman, K
,
Konieczny, A
Format:
Conference item
Izdano:
2008
Primjerci
Opis
Slični predmeti
Prikaz za djelatnike knjižnice
Slični predmeti
The final results of the interferon beta-1b 16-year long-term follow-up study
od: Ebers, G, i dr.
Izdano: (2006)
Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study.
od: Ebers, G, i dr.
Izdano: (2009)
Cross-sectional study assessing long-term safety of interferon-beta-1b for relapsing-remitting MS.
od: Reder, A, i dr.
Izdano: (2010)
Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis
od: Goodin, D, i dr.
Izdano: (2012)
Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis.
od: Goodin, D, i dr.
Izdano: (2012)